nitrates has been researched along with Cardiac Remodeling, Ventricular in 13 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
| Excerpt | Relevance | Reference |
|---|---|---|
| "enalapril alone to enhance vascular effects, increase LV contractility and prevent unfavorable remodeling and are consistent with vascular delivery of exogenous NO." | 5.32 | A nitric oxide-releasing derivative of enalapril, NCX 899, prevents progressive cardiac dysfunction and remodeling in hamsters with heart failure. ( Condorelli, G; Del Soldato, P; Dieterle, T; Gu, Y; Iwanaga, Y; Ongini, E; Peterson, KL; Presotto, C; Ross, J, 2004) |
| " Besides these proteases, several investigations have demonstrated that reduced endogenous NO bioavailability is a central pathological event in hypertension." | 2.72 | Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension. ( Batista, RIM; Guimaraes, DA; Tanus-Santos, JE, 2021) |
| "enalapril alone to enhance vascular effects, increase LV contractility and prevent unfavorable remodeling and are consistent with vascular delivery of exogenous NO." | 1.32 | A nitric oxide-releasing derivative of enalapril, NCX 899, prevents progressive cardiac dysfunction and remodeling in hamsters with heart failure. ( Condorelli, G; Del Soldato, P; Dieterle, T; Gu, Y; Iwanaga, Y; Ongini, E; Peterson, KL; Presotto, C; Ross, J, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Guimaraes, DA | 1 |
| Batista, RIM | 1 |
| Tanus-Santos, JE | 1 |
| Gee, LC | 1 |
| Massimo, G | 1 |
| Lau, C | 1 |
| Primus, C | 1 |
| Fernandes, D | 1 |
| Chen, J | 1 |
| Rathod, KS | 1 |
| Hamers, AJP | 1 |
| Filomena, F | 1 |
| Nuredini, G | 1 |
| Ibrahim, AS | 1 |
| Khambata, RS | 1 |
| Gupta, AK | 1 |
| Moon, JC | 1 |
| Kapil, V | 1 |
| Ahluwalia, A | 1 |
| Bunbupha, S | 1 |
| Prachaney, P | 1 |
| Kukongviriyapan, U | 1 |
| Kukongviriyapan, V | 1 |
| Welbat, JU | 1 |
| Pakdeechote, P | 1 |
| Akcaboy, M | 1 |
| Kula, S | 1 |
| Göktas, T | 1 |
| Nazlıel, B | 1 |
| Terlemez, S | 1 |
| Celik, N | 1 |
| Celik, B | 1 |
| Buyan, N | 1 |
| Jacoby, D | 1 |
| Albajrami, O | 1 |
| Bellumkonda, L | 1 |
| Agata, J | 3 |
| Chao, L | 3 |
| Chao, J | 3 |
| Levine, TB | 1 |
| Levine, AB | 1 |
| Bolenbaugh, J | 1 |
| Green, PR | 1 |
| Iwanaga, Y | 1 |
| Gu, Y | 1 |
| Dieterle, T | 1 |
| Presotto, C | 1 |
| Del Soldato, P | 1 |
| Peterson, KL | 1 |
| Ongini, E | 1 |
| Condorelli, G | 1 |
| Ross, J | 1 |
| Tiyyagura, SR | 1 |
| Pinney, SP | 1 |
| Ura, N | 1 |
| Yoshida, H | 2 |
| Shinshi, Y | 1 |
| Sasaki, H | 1 |
| Hyakkoku, M | 1 |
| Taniguchi, S | 1 |
| Shimamoto, K | 1 |
| Yao, YY | 1 |
| Yin, H | 1 |
| Shen, B | 1 |
| Yang, HY | 1 |
| Yang, SC | 1 |
| Chen, ST | 1 |
| Chen, JR | 1 |
| Wolf, WC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Management of Renin-Angiotensin-Aldosterone System Blockade in Patients Admitted in Hospital With Confirmed Coronavirus Disease (COVID-19) Infection: The McGill RAAS-COVID-19 Randomized Controlled Trial[NCT04508985] | 46 participants (Actual) | Interventional | 2020-10-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for nitrates and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension.
Topics: Animals; Antihypertensive Agents; Arteries; Heart; Humans; Hypertension; Hypertrophy, Left Ventricul | 2021 |
Left ventricular remodeling after myocardial infarction: past, present, and future.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertrop | 2006 |
11 other studies available for nitrates and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Inorganic nitrate attenuates cardiac dysfunction: roles for xanthine oxidoreductase and nitric oxide.
Topics: Animals; Cardiomegaly; Case-Control Studies; Clinical Studies as Topic; Disease Models, Animal; Fibr | 2022 |
Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Collagen; Disease Models, Anima | 2015 |
Effect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patients.
Topics: Adolescent; Biomarkers; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Echocardiograph | 2016 |
Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiac Resynch | 2011 |
Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction.
Topics: Adenoviridae; Animals; Apoptosis; Cell Survival; Disease Models, Animal; Dobutamine; Gene Transfer T | 2002 |
Reversal of heart failure remodeling: is it maintained?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiomyopathies; Echocardiography; Female | 2003 |
A nitric oxide-releasing derivative of enalapril, NCX 899, prevents progressive cardiac dysfunction and remodeling in hamsters with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Cardiomyopathy, Dilated; Cricetinae; Cytos | 2004 |
Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Con | 2006 |
Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
Topics: Animals; Capillaries; Cardiac Output, Low; Cardiomegaly; Cells, Cultured; Collagen; Coronary Vessels | 2007 |
Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with L-NAME-induced hypertension.
Topics: Alanine Transaminase; Animals; Aorta; Aspartate Aminotransferases; Blood Pressure; Hydrolysis; Hyper | 2008 |
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
Topics: Adenoviridae; Animals; Blood Pressure; Blood Urea Nitrogen; Cardiomegaly; Cyclic GMP; Fibrosis; Gene | 2000 |